Pfizer, Inc. (PFE)
Track the next or latest earnings date for Pfizer, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
No recent earnings news is available right now.
Latest earnings date
Time not specified
Fiscal quarter: 2025-12-31
EPS estimate: $0.57
Revenue estimate: N/A
Market cap: $156.19B
AI earnings summary
Management provided conservative 2026 guidance, which contributed to market concerns despite strong Q4 operational performance. The company faces a $1.5 billion patent cliff challenge in 2026 and continuing decline in COVID-19 product revenues.
Sentiment and reaction
Sentiment score: +70.00%
Post-earnings price reaction: -4.54%
EPS
Estimate: $0.57
Actual: $0.66
Surprise: +15.79%
Revenue
Estimate: N/A
Actual: $17.60B
Surprise: N/A
Financial highlights
• Q4 2025 EPS of $0.66, beating estimates by 15.79% • Revenue of $17.6 billion for the quarter • Full-year 2025 revenue was $62.58 billion, down -1.65% year-over-year • Full-year 2025 earnings were $7.77 billion, down -3.24% year-over-year • Non-COVID portfolio posted 9% operational growth in 2025 • Underlying operational strength evident despite revenue decline • Market cap of $156.81 billion as of latest trading
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Feb 03, 2026 | 2025-12-31 | Time not specified | $0.57 | N/A |